#afoxolaner

4

FDA approves NexGard expanded label claims

August 22, 2018

Merial, part of Boehringer Ingelheim, received approval from the U.S Food and Drug Administration to expand the label claims for NexGard (afoxolaner). The flea and tick control product is now approved to prevent Borrelia burgdorferi infections as a direct result of it killing Ixodes scapularis vector ticks, commonly called black-legged, or deer, ticks. NexGard is the first and only flea and tick product to receive FDA approval for preventing infections that cause Lyme disease …
New on

Join VPN Plus+ today to get access to exclusive content like:

Veterinary medicine is losing its personal touch 
Cytology for Technicians
A look inside the open-hospital model of veterinary care
Canine Otitis Externa—Proper Work Up For This “Ear-Y” Occurrence
Join Now!
bocoran admin jarwo